RecruitingNot ApplicableNCT07508904

Exercises' Effect on Muscle Strength, Aerobic Capacity and Respiratory Functions in Cystic Fibrosis

Effects of Upper and Lower Limb Exercises on Muscle Strength, Aerobic Capacity and Respiratory Functions in Children With Cystic Fibrosis


Sponsor

Riphah International University

Enrollment

22 participants

Start Date

Dec 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This research aims to evaluate the effects of upper and lower limb exercises on muscle strength and pulmonary function in children diagnosed with CF. While aerobic training is a known component of CF management, resistance training focused on specific limb groups has gained attention for its additional benefits. Upper limb exercises may aid respiratory muscle endurance and thoracic mobility, enhancing pulmonary mechanics. In contrast, lower limb exercises (such as cycling or squats) are associated with improved oxygen consumption (VO₂ peak), enhanced mobility, and greater lower body strength. This randomized clinical trial will be conducted using a non-probability convenience sampling technique. The study will take place at the pediatric cystic fibrosis centers of Gulab Devi Chest Hospital and The Children's Hospital, Lahore. The targeted population includes children aged 6 to 18 years who have been diagnosed with cystic fibrosis and referred to the physiotherapy department. The study duration will be ten months following the approval of the synopsis. Eligible participants will be children aged between 6 and 18 years, clinically diagnosed with cystic fibrosis, currently stable with no history of hospitalization or significant lung infection in the past month. They should be physically able to participate in exercise and capable of following instructions, with informed consent obtained from their parents or guardians. Children will be excluded if they suffer from other severe lung diseases, cardiovascular or orthopedic conditions that restrict exercise, recent surgery or hospitalization within the last month, or if they are unable to understand instructions. Those dependent on oxygen therapy or ventilator support at all times will also be excluded. The primary outcome measures will include lung function assessed by spirometry (FVC, FEV1), sputum production recorded through a sputum diary, and aerobic capacity measured by the Incremental Shuttle Walk Test (ISWT). Muscle strength will be evaluated for both upper and lower limbs, using a handheld dynamometer for the upper limbs and the Sit-to-Stand Test for the lower limb


Eligibility

Min Age: 6 YearsMax Age: 18 Years

Inclusion Criteria5

  • Children aged 6-18 years
  • Diagnosed with cystic fibrosis
  • Clinically stable
  • Able to perform exercise
  • Parental/guardian consent provided

Exclusion Criteria5

  • Other severe pulmonary diseases
  • Cardiovascular or orthopedic limitations
  • Surgery or hospitalization within last 1 month
  • Inability to follow instructions
  • Oxygen-dependent or ventilator-dependent patients

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERArm Cycle Ergometry

Participants will undergo upper limb resistance training using an arm cycle ergometer

OTHERLeg Cycle Ergometry

Participants will undergo lower limb resistance training using a leg cycle ergometer


Locations(1)

Gulab Devi Chest Hospital

Lahore, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07508904


Related Trials